ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 216 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,793 | +41.4% | 9,269 | +35.8% | 0.00% | – |
| Q2 2023 | $86,108 | +66.9% | 6,825 | +72.4% | 0.00% | – |
| Q1 2023 | $51,602 | -39.6% | 3,959 | -18.1% | 0.00% | – |
| Q4 2022 | $85,369 | +35.5% | 4,833 | +15.6% | 0.00% | – |
| Q3 2022 | $63,000 | +50.0% | 4,182 | +46.5% | 0.00% | – |
| Q2 2022 | $42,000 | -96.0% | 2,854 | -93.8% | 0.00% | -100.0% |
| Q1 2022 | $1,038,000 | +2156.5% | 46,128 | +1734.1% | 0.00% | – |
| Q4 2021 | $46,000 | +48.4% | 2,515 | +7.8% | 0.00% | – |
| Q3 2021 | $31,000 | -42.6% | 2,334 | -20.2% | 0.00% | – |
| Q2 2021 | $54,000 | +38.5% | 2,923 | +10.5% | 0.00% | – |
| Q1 2021 | $39,000 | +5.4% | 2,646 | 0.0% | 0.00% | – |
| Q4 2020 | $37,000 | -7.5% | 2,646 | -47.9% | 0.00% | – |
| Q3 2020 | $40,000 | +29.0% | 5,076 | +7.8% | 0.00% | – |
| Q2 2020 | $31,000 | -8.8% | 4,709 | -3.2% | 0.00% | – |
| Q1 2020 | $34,000 | – | 4,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |